CAS No. 396104-51-1

4,7,13,16,21,24-Hexaoxabicyclo[8.8.8]hexacosane

4,7,13,16,21,24-Hexaoxabicyclo[8.8.8]hexacosane
CAS 396104-51-1 molecular structure
Product Code
996241
Product Name
4,7,13,16,21,24-Hexaoxabicyclo[8.8.8]hexacosane
CAS Number
396104-51-1
Molecular Formula
C20H38O6
Product Synonyms
hexacosane
hexaoxabicyclo
  • 2,4-Pyrimidinediamine,6-(3-butenyl)-5-[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]phenyl]-
  • 2H-1-Benzopyran-2,5(3H)-dione,4-(2-chlorophenyl)-4,6,7,8-tetrahydro-7,7-dimethyl-
  • 2,4-Pyrimidinediamine,6-[(phenylmethoxy)methyl]-5-[4-[[1-(4-pyridinyl)ethyl]amino]phenyl]-
  • 1-{4-[(diphenylacetyl)oxy]but-2-yn-1-yl}pyrrolidinium chloride
  • 1,2,4-Butanetrione, 1,4-bis(4-methoxyphenyl)-
  • 2-Butenamide, N-(bromoacetyl)-, (2E)-
    102040-94-8
  • 2-Butenamide, N-(5-chloro-2-methylphenyl)-3-(1-piperidinyl)-
  • Methanone, (5-amino-2-chloro-4-pyridinyl)phenyl-
  • 2,4-Pyrimidinediamine,5-[4-[[(3,4-dichlorophenyl)methyl]amino]phenyl]-6-ethyl-
  • 2,4-Pyrimidinediamine,5-(3-chlorophenyl)-6-[2-(3-phenoxypropoxy)ethyl]-
  • 2-Butenamide,N-(2,6-dimethylphenyl)-4-oxo-4-(3,4,5-trimethoxyphenyl)-
  • 1-phenyl-2,5,8,11,14-pentaoxahexadecan-16-yl dihydrogen phosphate, compound with morpholine (1:1)
    99670-24-3
  • 2,4-Pyrimidinediamine,5-[[2-[(4-fluorophenyl)methyl]-6,7-dimethoxy-4-benzofuranyl]methyl]-
  • 2,4-Pyrimidinediamine,6-ethyl-5-[1-[[4-(methylsulfonyl)phenyl]methyl]-1H-indol-5-yl]-
  • 1-(2-Thienylmethyl)piperidin-4-amine
  • [2-(aminomethyl)phenyl]-1-pyrrolidinyl-methanone
  • 2,3-Butanedione, O-aminooxime oxime
  • 2-Butenamide, 4-oxo-4-phenyl-N-(2,4,6-trichlorophenyl)-
    56428-51-4
  • 2,4-Pyrimidinediamine,6-ethyl-5-[1-[[4-(methylsulfonyl)phenyl]methyl]-2-phenyl-1H-benzimidazol-5-yl]-
  • 3-Bromo-3',3''-difluorotritylalcohol
  • (2S)-2-AMINO-2,3-DIMETHYL-BUTANENITRILE D-(-)-TARTARIC ACID
  • 2-Furanacetic acid, a-[(chloroacetyl)amino]-, (R)-
  • 2,3-Diazabicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid,1,4-dimethyl-7-oxo-5,6-diphenyl-, dimethyl ester
  • 2,4-Pyrrolidinedicarboxylic acid, 5-[(1S)-1-(acetylamino)-3-ethylpentyl]-,4-methyl ester, (2R,4R,5R)-
    492462-22-3
  • 1,2,4-Triazine-3,5(2H,4H)-dione, 6-butyldihydro-
  • 4-Bromo-3',3''-dichlorotritylalcohol
  • 2,4-Pyrimidinediamine,5-[[3,4-bis(phenylmethoxy)phenyl]methyl]-6-ethyl-
  • N-((3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl)-4-(2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)piperidine-1-carboxamide
  • 2,4-Pyrrolidinedione,3-(1-hydroxy-11-methyldodecylidene)-1,5-dimethyl-, (3Z)-
  • 2,4-Pyrimidinediamine,6-[(3,4-dihydro-2(1H)-isoquinolinyl)methyl]-5-[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]phenyl]-
    861221-23-0
  • 2-Butenamide, N-(3-bromophenyl)-2-cyano-3-ethoxy-
  • 1,2-Ethanediamine, N,N-diethyl-N'-(7-nitro-2,1,3-benzoxadiazol-4-yl)-
  • 3,3'-Difluoro-3''-methyltrityl alcohol
  • 2-Butenamide, 4-(4-chlorophenyl)-2-hydroxy-4-oxo-N-2-thiazolyl-
  • 2,3-Butanediol,1-[(3R,5R)-2,3,4,5-tetrahydro-3,5-dimethyl-1,4-benzoxazepin-5-yl]-, rel-
  • 1,4-Dioxaspiro[4.5]decane, 9-methyl-6-(1-methylethyl)-, trans-
    116549-07-6